These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2536896)

  • 1. Racial differences in drug response. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites.
    Zhou HH; Koshakji RP; Silberstein DJ; Wilkinson GR; Wood AJ
    N Engl J Med; 1989 Mar; 320(9):565-70. PubMed ID: 2536896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnic differences in response to non-selective beta-blockade among racial groups in Malaysia.
    Rasool AH; Rahman AR; Ismail R; Hatim S; Abdullah AR; Singh R; Haron R
    Int J Clin Pharmacol Ther; 2000 May; 38(5):260-9. PubMed ID: 10839470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased suppression of exercise-induced increase in renin by propranolol in Chinese subjects.
    Zhou HH; Wood AJ
    Clin Pharmacol Ther; 1991 Aug; 50(2):150-6. PubMed ID: 1868676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in stereoselective disposition of propranolol do not explain sensitivity differences between white and Chinese subjects: correlation between the clearance of (-)- and (+)-propranolol.
    Zhou HH; Wood AJ
    Clin Pharmacol Ther; 1990 Jun; 47(6):719-23. PubMed ID: 2357866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial differences in beta-adrenoceptor-mediated responsiveness.
    Johnson JA; Burlew BS; Stiles RN
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):90-6. PubMed ID: 7723360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of differences in plasma binding of propranolol to ethnic differences in sensitivity. Comparison between Chinese and Caucasians.
    Zhou HH; Shay SD; Wood AJ
    Chin Med J (Engl); 1993 Dec; 106(12):898-902. PubMed ID: 8143506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response relationships of propranolol in Chinese subjects with different CYP2D6 genotypes.
    Huang CW; Lai ML; Lin MS; Lee HL; Huang JD
    J Chin Med Assoc; 2003 Jan; 66(1):57-62. PubMed ID: 12728976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial differences in sensitivity to the negative chronotropic effects of propranolol in healthy men.
    Sowinski KM; Burlew BS; Johnson JA
    Clin Pharmacol Ther; 1995 Jun; 57(6):678-83. PubMed ID: 7781268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial differences in propranolol pharmacokinetics.
    Johnson JA; Burlew BS
    Clin Pharmacol Ther; 1992 May; 51(5):495-500. PubMed ID: 1587062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial differences in lymphocyte beta-receptor sensitivity to propranolol.
    Johnson JA
    Life Sci; 1993; 53(4):297-304. PubMed ID: 8392129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial differences in propranolol enantiomer kinetics following simultaneous i.v. and oral administration.
    Sowinski KM; Lima JJ; Burlew BS; Massie JD; Johnson JA
    Br J Clin Pharmacol; 1996 Sep; 42(3):339-46. PubMed ID: 8877025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interindividual differences in beta-receptor density contribute to variability in response to beta-adrenoceptor antagonists.
    Zhou HH; Silberstein DJ; Koshakji RP; Wood AJ
    Clin Pharmacol Ther; 1989 Jun; 45(6):587-92. PubMed ID: 2543534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men.
    Sklar J; Johnston GD; Overlie P; Gerber JG; Brammell HL; Gal J; Nies AS
    Circulation; 1982 May; 65(5):894-9. PubMed ID: 7074750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular hemodynamics of bicycle and handgrip exercise in normal subjects before and after administration of propranolol.
    Clements IP; Offord KP; Baron DW; Brown ML; Bardsley WT; Harrison CE
    Mayo Clin Proc; 1984 Sep; 59(9):604-11. PubMed ID: 6471920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta blockade by oral propranolol and labetalol.
    Cubeddu LX; Carr ME; Fuenmayor NJ
    Clin Pharmacol Ther; 1985 Mar; 37(3):277-83. PubMed ID: 2857602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of S-596, a new beta-adrenoceptor blocking agent on the left ventricular performance of normal subjects during exercise.
    Nishida K; Niki S; Furukawa K; Yamada C; Sugihara H; Katsume H; Ijichi H
    Jpn Heart J; 1985 May; 26(3):437-49. PubMed ID: 2411959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different antihypertensive effect of beta-blocking drugs in low and normal-high renin hypertension.
    Kralberg BE; Tolagen K
    Am J Med; 1976 May; 60(6):891-6. PubMed ID: 14504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomic regulation of heart rate response to exercise in Tibetan and Han residents of Lhasa (3,658 m).
    Zhuang J; Droma T; Sutton JR; McCullough RE; McCullough RG; Groves BM; Rapmund G; Janes C; Sun S; Moore LG
    J Appl Physiol (1985); 1993 Nov; 75(5):1968-73. PubMed ID: 8307847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced exercise noradrenaline concentrations during propranolol treatment: a limiting factor in cardiac beta-adrenoceptor blockade.
    Hurwitz GA; Webb JG; Walle T; Gourley LA; Cobb L
    Can J Cardiol; 1988 Sep; 4(6):262-9. PubMed ID: 2846132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenergic modulation of potassium metabolism in uremia.
    Castellino P; Bia MJ; DeFronzo RA
    Kidney Int; 1990 Feb; 37(2):793-8. PubMed ID: 2308263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.